Breaking News Instant updates and real-time market news.

AVP

Avon Products

$3.06

0.28 (10.07%)

09:24
03/25/19
03/25
09:24
03/25/19
09:24

Avon Products buyout could be valued as high as $4.50/shr, says DA Davidson

DA Davidson analyst Linda Bolton Weiser kept her Buy rating and $3.50 price target on Avon Products after the latest speculation about its potential acquisition by Natura. The analyst believes that the takeout valuation could come at $3.80-$4.50 per share, but intends to assess the Brazil anti-trust rules while also noting Natura's already "leveraged balance sheet, with over $2B of debt and debt-to-EBITDA of 4.3-times".

AVP Avon Products
$3.06

0.28 (10.07%)

09/18/18
DADA
09/18/18
NO CHANGE
DADA
Neutral
Avon CEO likely to get time before board considers sale, says DA Davidson
DA Davidson analyst Linda Bolton Weiser thinks the board of Avon Products (AVP) will give new CEO Jan Zijderveld a period of time to improve financial performance before seriously considering a sale of the company. With Zijderveld set to unveil his turnaround strategy on September 21, the Wall Street Journal reported last night that Brazilian beauty direct seller Natura recently approached Avon about a takeover, Bolton Weiser tells investors in a research note titled "What Will Become of Avon?" Natura said in a statement, however, that there are no negotiations in progress concerning a possible acquisition of Avon, the analyst points out. She doubts that the board and Cerberus would find it prudent to sell the company when the share price is around $2. With that said, Bolton Weiser notes that Avon's takeout valuation is $7.75 per share based on Coty's (COTY) 2012 offer. In April 2012, Coty offered $23.25 per share for Avon, a 27% premium, and later raised it to $24.75 per share, or $10.7B, the analyst recalls. She notes the offer was withdrawn in May 2012. Bolton Weiser has a Neutral rating on Avon Products with a $1.75 price target. The stock in late morning trading is up 8%, or 16c, to $2.24.
09/24/18
DADA
09/24/18
UPGRADE
DADA
Buy
Avon Products upgraded to Buy from Neutral at DA Davidson
09/24/18
DADA
09/24/18
UPGRADE
Target $3.5
DADA
Buy
Avon Products upgraded to Buy at DA Davidson on operational focus of new CEO
As reported earlier, DA Davidson analyst Linda Bolton Weiser upgraded Avon Products (AVP) to Buy from Hold and raised her price target to $3.50 from $1.75. The analyst cites the increased "sense of urgency" under the new CEO Jan Zijderveld displayed in his first analyst meeting, demonstrating his greater engagement in the company's operations, hiring of executives with sales experience, and "establishing a culture of accountability". Based on her increased confidence in Avon's management team, Weiser also raised her target enterprise value to expected FY20 EBITDA target multiple to 6.5-times from 4.5-times, which is still a discount to other direct sellers like Nu Skin (NUS) and Herablife (HLF) trading at 11- to 12-times
09/24/18
09/24/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Plains All American (PAA) and Plains GP Holdings (PAGP) were upgraded to Buy from Hold at Stifel. 2. Avon Products (AVP) upgraded to Buy from Neutral at DA Davidson with analyst Linda Bolton Weiser citing the increased "sense of urgency" under the new CEO Jan Zijderveld displayed in his first analyst meeting, demonstrating his greater engagement in the company's operations, hiring of executives with sales experience, and "establishing a culture of accountability." 3. United Natural Foods (UNFI) upgraded to Sector Perform at RBC Capital with analyst William Kirk saying while core business challenges for the company remain and the risk of the Supervalu acquisition integration continues, its 6.4-times earnings valuation likely accounts for these issues. 4. KVH Industries (KVHI) upgraded to Buy from Neutral at Chardan with analyst James McIlree saying he expects "continued strong growth" from its Agile Plans that should result in improved margins and increased financial predictability. 5. RELX (RELX) upgraded to Overweight from Equal Weight at Barclays with analyst Nick Dempsey saying he views the current valuation as attractive. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

ALGT

Allegiant Travel

$172.80

0.57 (0.33%)

11:06
12/11/19
12/11
11:06
12/11/19
11:06
Hot Stocks
Allegiant Travel reports November scheduled service RPMs up 1.6% »

Allegiant Travel reported…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HII

Huntington Ingalls

$251.05

-0.74 (-0.29%)

11:05
12/11/19
12/11
11:05
12/11/19
11:05
Hot Stocks
Huntington Ingalls appoints Bharat Amin as EVP, CIO »

Huntington Ingalls…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CIEN

Ciena

$35.35

0.65 (1.87%)

11:05
12/11/19
12/11
11:05
12/11/19
11:05
Options
Ciena call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

AMZN

Amazon.com

$1,738.75

-0.4 (-0.02%)

11:01
12/11/19
12/11
11:01
12/11/19
11:01
Periodicals
Alexa devices sell out in parts of Europe before Christmas, Bloomberg reports »

Amazon's new…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EVER

EverQuote

$34.09

-1.95 (-5.41%)

11:01
12/11/19
12/11
11:01
12/11/19
11:01
On The Fly
EverQuote down after Bonitas says it expects stock to drop to about $5 »

Shares of EverQuote…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:01
12/11/19
12/11
11:01
12/11/19
11:01
Conference/Events
JPMorgan banking analyst to hold an analyst/industry conference call »

U.S. Mid & Small Cap…

LOGM

LogMeln

$74.20

0.24 (0.32%)

10:59
12/11/19
12/11
10:59
12/11/19
10:59
Hot Stocks
Breaking Hot Stocks news story on LogMeln 

LogMein trading resumes

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LOGM

LogMeln

$74.20

0.24 (0.32%)

10:58
12/11/19
12/11
10:58
12/11/19
10:58
Hot Stocks
LogMeln up 6% after report of private equity takeover talks »

Shares of LogMeIn are up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LOGM

LogMeln

$74.20

0.24 (0.32%)

10:55
12/11/19
12/11
10:55
12/11/19
10:55
Periodicals
PE firms in talks to buy LogMeln, Bloomberg says »

Francisco Partners and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SDC

SmileDirectClub

$7.89

-0.06 (-0.75%)

10:55
12/11/19
12/11
10:55
12/11/19
10:55
Options
SmileDirectClub put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SWI

SolarWinds

$18.07

-0.11 (-0.61%)

10:55
12/11/19
12/11
10:55
12/11/19
10:55
Conference/Events
SolarWinds to host analyst & investor day »

Analyst & Investor…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

LOGM

LogMeln

$74.20

0.24 (0.32%)

10:54
12/11/19
12/11
10:54
12/11/19
10:54
Hot Stocks
Breaking Hot Stocks news story on LogMeln »

LogMein trading halted,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XP

XP

$0.00

(0.00%)

10:53
12/11/19
12/11
10:53
12/11/19
10:53
Syndicate
Breaking Syndicate news story on XP »

XP indicated to open at…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

MNST

Monster Beverage

$62.03

0.51 (0.83%)

10:45
12/11/19
12/11
10:45
12/11/19
10:45
Options
Monster Beverage call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:45
12/11/19
12/11
10:45
12/11/19
10:45
General news
Energy Action: WTI crude »

Energy Action: WTI crude…

CI

Cigna

$190.86

-0.88 (-0.46%)

, CVS

CVS Health

$73.06

-0.11 (-0.15%)

10:42
12/11/19
12/11
10:42
12/11/19
10:42
On The Fly
Cigna downgrade, Apple, PC&G target raises among today's top calls »

Check out today's top…

CI

Cigna

$190.86

-0.88 (-0.46%)

CVS

CVS Health

$73.06

-0.11 (-0.15%)

AMZN

Amazon.com

$1,740.89

1.74 (0.10%)

NFLX

Netflix

$298.30

5.09 (1.74%)

UPS

UPS

$117.55

-0.94 (-0.79%)

PCG

PG&E

$12.94

0.61 (4.95%)

AAPL

Apple

$270.44

1.82 (0.68%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Jan

  • 06

    Feb

ALKS

Alkermes

$21.49

-0.08 (-0.37%)

10:40
12/11/19
12/11
10:40
12/11/19
10:40
Hot Stocks
FDA issues warning letter to Alkermes over print ad for Vivitrol »

In a warning letter dated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NLOK

NortonLifeLock

$26.39

0.1 (0.38%)

10:35
12/11/19
12/11
10:35
12/11/19
10:35
Options
NortonLifeLock put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Dec

EVER

EverQuote

$35.00

-1.04 (-2.89%)

10:33
12/11/19
12/11
10:33
12/11/19
10:33
Periodicals
EverQuote named as short idea by Bonitas Research 

Reference Link

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XP

XP

$0.00

(0.00%)

10:30
12/11/19
12/11
10:30
12/11/19
10:30
Syndicate
Breaking Syndicate news story on XP »

XP indicated to open at…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

USO

United States Oil Fund

$12.35

-0.04 (-0.32%)

10:30
12/11/19
12/11
10:30
12/11/19
10:30
General news
Crude inventories for week of December 6 »

Crude oil inventories…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CI

Cigna

$191.14

-0.6 (-0.31%)

, MET

MetLife

$49.25

-0.04 (-0.08%)

10:28
12/11/19
12/11
10:28
12/11/19
10:28
On The Fly
Street Fight: Cigna sparks analyst debate over PillPack news, possible unit sale »

Shares of Cigna (CI) are…

CI

Cigna

$191.14

-0.6 (-0.31%)

MET

MetLife

$49.25

-0.04 (-0.08%)

SLF

Sun Life Financial

$44.82

0.04 (0.09%)

WBA

Walgreens Boots Alliance

$57.92

-0.48 (-0.82%)

WCG

WellCare

$317.16

-2.3 (-0.72%)

ACHC

Acadia

$31.73

-0.37 (-1.15%)

EHC

Encompass Health

$70.90

-0.88 (-1.23%)

ANTM

Anthem

$281.14

-2.45 (-0.86%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 08

    Jan

  • 06

    Feb

  • 13

    Feb

XP

XP

$0.00

(0.00%)

10:24
12/11/19
12/11
10:24
12/11/19
10:24
Syndicate
XP indicated to open at $34.00, IPO priced at $27.00 »

XP (XP) priced 72.5M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

10:22
12/11/19
12/11
10:22
12/11/19
10:22
Conference/Events
JPMorgan healthcare tech analyst to hold an analyst/industry conference call »

Healthcare Technology…

F

Ford

$9.12

0.045 (0.50%)

10:20
12/11/19
12/11
10:20
12/11/19
10:20
Options
Long-dated put sale in Ford sold tied to hedge possibly closes »

Long-dated put sale in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Jan

  • 04

    Feb

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.